Daniel Carpio
Overview
Explore the profile of Daniel Carpio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giordano A, Perez-Martinez I, Gisbert J, Ricart E, Martin-Arranz M, Mesonero F, et al.
Am J Gastroenterol
. 2025 Jan;
120(1):194-203.
PMID: 39745305
Introduction: Crohn's disease (CD) varies by location, potentially affecting therapy efficacy and surgery risk, although research on this topic is conflicting. This study aims to investigate the independent association between...
2.
Marin-Jimenez I, Carpio D, Hernandez V, Munoz F, Zatarain-Nicolas E, Zabana Y, et al.
Gastroenterol Hepatol
. 2024 Nov;
502314.
PMID: 39615874
Cardiovascular diseases (CVD) are the leading cause of death worldwide. Therefore, it is essential to understand their relationship and prevalence in different diseases that may present specific risk factors for...
3.
Ricart E, Bastida G, Carpio D, Ceballos D, Ginard D, Marin-Jimenez I, et al.
Crohns Colitis 360
. 2024 Oct;
6(4):otae055.
PMID: 39445340
Background: We aimed to (1) analyze the applicability of the updated Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations in real-world clinical practice, (2) identify barriers to their implementation,...
4.
Yanez A, Jaramillo K, Silva P, Yanez A M, Sandoval M, Carpio D, et al.
Am J Med Sci
. 2024 Jun;
368(5):518-531.
PMID: 38944202
Background: Diabetic Nephropathy is one of the most severe complications of Diabetes Mellitus and the main cause of end-stage kidney disease worldwide. Despite the therapies available to control blood glucose...
5.
Gonzalez-Munoza C, Calafat M, Gisbert J, Iglesias E, Minguez M, Sicilia B, et al.
Postgrad Med J
. 2024 Jun;
100(1189):836-844.
PMID: 38913019
Background And Aims: Familial inflammatory bowel disease (IBD) history is a controversial prognostic factor in IBD. We aimed to evaluate the impact of a familial history of IBD on the...
6.
Casanova M, Caballol B, Garcia M, Mesonero F, Rubin de Celix C, Suarez-Alvarez P, et al.
Dig Liver Dis
. 2024 Jun;
56(11):1845-1853.
PMID: 38839456
Background: The efficacy of ustekinumab and vedolizumab for treating complex perianal fistula in Crohn's disease has been barely studied. We aimed to assess treatment persistence, clinical remission, and safety of...
7.
Gargallo-Puyuelo C, Ricart E, Iglesias E, de Francisco R, Gisbert J, Taxonera C, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(11):2280-2290.
PMID: 38782172
Background & Aims: The impact of patient sex on the presentation of inflammatory bowel disease (IBD) has been poorly evaluated. Our aims were to assess potential disparities in IBD phenotype...
8.
Gonzalez-Lama Y, Ricart E, Carpio D, Bastida G, Ceballos D, Ginard D, et al.
BMJ Open Gastroenterol
. 2024 Jan;
11(1).
PMID: 38267072
Background: Despite research, there are still controversial areas in the management of Crohn's disease (CD). Objective: To establish practical recommendations on using anti-tumour necrosis factor (TNF) drugs in patients with...
9.
Schulz I, Kutscher A, Krall P, Carpio D, Ardiles L
Kidney Int Rep
. 2023 Dec;
8(12):2838-2841.
PMID: 38106599
No abstract available.
10.
Zabana Y, Marin-Jimenez I, Rodriguez-Lago I, Vera I, Martin-Arranz M, Guerra I, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556155
(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to...